EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility

Shivraj M Yabaji iD, Vadim Zhernovkov iD, Prasanna Babu Araveti iD, Suruchi Lata iD, Oleksii S Rukhlenko iD, Salam Al Abdullatif, Arthur Vanvalkenburg iD, Yuriy O Alekseyev iD, Qicheng Ma, Gargi Dayama, Nelson C Lau iD, W Evan Johnson iD und 7 weitere

eLife · 2025

DOI: 10.7554/elife.106814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Shivraj M Yabaji und 18 weiteren Autor:innen. Beteiligte Einrichtung: The National Emerging Infectious Diseases Laboratory, Boston University, Boston, United States. Hauptthemen laut MEDLINE: Macrophage Activation, Mycobacterium tuberculosis, Lipid Peroxidation, Interferon Type I. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A quarter of the human population is infected with Mycobacterium tuberculosis , but less than 10% of those infected develop pulmonary TB. We developed a genetically defined sst1-susceptible mouse model that uniquely reproduces a defining feature of human TB: the development of necrotic lung granulomas and determined that the sst1-susceptible phenotype was driven by the aberrant macrophage activation. This study demonstrates that the aberrant response of the sst1-susceptible macrophages to prolonged stimulation with TNF is primarily driven by conflicting Myc and antioxidant response pathways leading to a coordinated failure (1) to properly sequester intracellular iron and (2) to activate ferroptosis inhibitor enzymes. Consequently, iron-mediated lipid peroxidation fueled superinduction of Ifnβ and sustained the type I interferon (IFN-I) pathway hyperactivity that locked the sst1-susceptible macrophages in a state of unresolving stress and compromised their resistance to Mtb. The accumulation of the aberrantly activated, stressed, macrophages within the granuloma microenvironment led to the local failure of anti-tuberculosis immunity and tissue necrosis. The upregulation of the Myc pathway in peripheral blood cells of human TB patients was significantly associated with poor outcomes of TB treatment. Thus, Myc dysregulation in activated macrophages results in an aberrant macrophage activation and represents a novel target for host-directed TB therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophage ActivationMycobacterium tuberculosisLipid PeroxidationInterferon Type IMacrophagesTuberculosisTuberculosis, PulmonaryAnimalsMiceHumansDisease Models, AnimalGranulomaDisease SusceptibilityMice, Inbred C57BL

Stichwörter der Autor:innen

MycType I interferonantioxidant defenseimmunologyinfectious diseaseinflammationlipid peroxidationmacrophagemicrobiologymousetuberculosis

Substanzen

Interferon Type I

Autor:innen und Institutionen

  • The National Emerging Infectious Diseases Laboratory, Boston University, Boston, United States.
  • Systems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland.
  • Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, United States.
  • Rutgers University, New Jersey Medical School, Center for Data Science, New Brunswick, United States.
  • Department of Medicine, Division of Infectious Disease, New Jersey Medical School, Rutgers University, New Brunswick, United States.
  • The Department of Pathology and Laboratory Medicine, Boston University Chobanian Avedisian School of Medicine, Boston, United States.

ORCID-Profile: Shivraj M Yabaji, Vadim Zhernovkov, Prasanna Babu Araveti, Suruchi Lata, Oleksii S Rukhlenko, Arthur Vanvalkenburg, Yuriy O Alekseyev, Nelson C Lau, W Evan Johnson, William R Bishai, Nicholas A Crossland, Joshua D Campbell, Boris N Kholodenko, Alexander A Gimelbrant, Lester Kobzik, Igor Kramnik

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute
  • NCI NIH HHS
  • Horizon Europe
  • NIGMS NIH HHS
  • Health Research Board, Ireland
  • Boston University
  • NIA NIH HHS

Zitieren

APA

Yabaji, S. M., Zhernovkov, V., Araveti, P. B., Lata, S., Rukhlenko, O. S., Abdullatif, S. A., Vanvalkenburg, A., Alekseyev, Y. O., Ma, Q., Dayama, G., Lau, N. C., Johnson, W. E., Bishai, W. R., Crossland, N. A., Campbell, J. D., Kholodenko, B. N., Gimelbrant, A. A., Kobzik, L., & Kramnik, I. (2025). Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility. eLife. https://doi.org/10.7554/elife.106814

Vancouver

Yabaji SM, Zhernovkov V, Araveti PB, Lata S, Rukhlenko OS, Abdullatif SA, et al. Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility. eLife. 2025. doi:10.7554/elife.106814

BibTeX
@article{Yabaji2025,
  author = {Yabaji, Shivraj M and Zhernovkov, Vadim and Araveti, Prasanna Babu and Lata, Suruchi and Rukhlenko, Oleksii S and Abdullatif, Salam Al and Vanvalkenburg, Arthur and Alekseyev, Yuriy O and Ma, Qicheng and Dayama, Gargi and Lau, Nelson C and Johnson, W Evan and Bishai, William R and Crossland, Nicholas A and Campbell, Joshua D and Kholodenko, Boris N and Gimelbrant, Alexander A and Kobzik, Lester and Kramnik, Igor},
  title = {Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.106814}
}
Kostenlos starten →